 BEVERLY, Mass., July 07, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., OTCQB: LXXGF; TSX-V: LXG the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced the release of its second-generation MiQLabTM Bacterial and AMR Antibiotic Antimicrobial Resistance Panel. 